Medical 49: Balanced Cannabinoids for Canadian Growers
Medical 49 stands out as a thoughtfully engineered strain for cultivators seeking equilibrium. This feminized offering blends Russian Snow hardiness, Skunk No.1 vigour, and AK-49 productivity into a single plant that thrives under indoor lights and outdoor Prairie or coastal conditions alike. With a 1:1 THC-to-CBD ratio and modest 8% THC, it occupies a sweet spot for those wanting active engagement without sedation. The 70% indica dominance ensures compact branching and predictable flowering within 8–9 weeks—a pace that aligns perfectly with Canada's shorter growing windows.
Cultivation Notes for Canadian Indoor & Outdoor
Medical 49 responds well to standard photoperiod management indoors, needing 12 hours darkness to trigger flowering. Expect medium internode spacing and lateral spread typical of indica hybrids; pruning early in veg helps air circulation in humid Maritime or Ontario basements. Outdoors, plant by late May in temperate zones to allow full maturation before autumn rains. The Russian Snow lineage confers cold tolerance, making this strain viable across much of Canada's growing region. Water needs are moderate; adjust for coastal drizzle or Prairie dry spells. Indoor growers in colder climates benefit from consistent 20–22 °C night temps during flowering to maximize resin production.
Effects & Flavour Profile
The balanced cannabinoid ratio produces clearheaded relaxation without heavy sedation, making Medical 49 suitable for daytime or early-evening use. Flavour notes lean toward earthy skunk and subtle herbal undertones, with a clean exhale. Terpene expression is modest but distinctive—expect pine and sage notes that sharpen when dried properly. This strain shines for those seeking functional engagement; the CBD presence rounds out THC's sharper edges, creating a mellowed yet aware state ideal for creative focus or gentle unwinding.
